Terazosin Hydrochloride
Product Images NDC 42549-666

5 FDA label images from Stat Rx Usa Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Terazosin Hydrochloride (NDC 42549-666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Stat Rx Usa Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Terazosin 4 mg Label 42549)

Label Image (Terazosin 4 mg Label   42549)
Label for Terazosin Hydrochloride 5mg capsules by STAT Rx USA LLC, packaged in a bottle of 30 capsules. The label states it is a generic for Hytrin and provides the NDC 42549-666-30. It includes manufacturer information, Jubilant Cadista Pharm. Inc., and warnings about potential side effects like dizziness and blurred vision.*
FDA Label Image

Structural Formula (A9fdefac 0145 4d34 Ab25 074bc534afaf 01)

Structural Formula (A9fdefac 0145 4d34 Ab25 074bc534afaf 01)
Chemical structure diagram of Terazosin Hydrochloride, showing the arrangement of its molecular components including aromatic rings, nitrogen atoms, and a piperazine ring connected to a carbonyl group, with an associated hydrochloride component.*
FDA Label Image

Figure 1 Study 1 (A9fdefac 0145 4d34 Ab25 074bc534afaf 02)

Figure 1 Study 1 (A9fdefac 0145 4d34 Ab25 074bc534afaf 02)
Two line graphs comparing placebo and terazosin groups over three months. The left graph shows a decrease in a variable from 0 to -7 over months for terazosin and a lesser decrease for placebo. The right graph shows an increase in a variable from 0 to 4 mL/sec with terazosin, while placebo shows a lower increase over the same period. Sample sizes are indicated (N=52-55).*
FDA Label Image

Image (A9fdefac 0145 4d34 Ab25 074bc534afaf 03)

Image (A9fdefac 0145 4d34 Ab25 074bc534afaf 03)
A line graph showing mean change from baseline over months 0 to 30. The y-axis measures mean change from baseline, with values decreasing from 0 to -7. Data points show a rapid initial decrease in mean change followed by a plateau, with significant changes marked by asterisks at earlier months. The x-axis is labeled in months.*
FDA Label Image

Image (A9fdefac 0145 4d34 Ab25 074bc534afaf 04)

Image (A9fdefac 0145 4d34 Ab25 074bc534afaf 04)
Line graph showing the mean change from baseline (mL/sec) over months 0 to 30, with data points and error bars. The y-axis represents mean change from baseline in milliliters per second, and the x-axis represents time in months. Several points on the graph are marked with asterisks indicating statistical significance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.